{ }
Very Negative
Negative
Neutral
Positive
Very Positive
2025-03-252025-03-252025-03-262025-03-262025-03-272025-03-272025-03-282025-03-282025-03-292025-03-292025-03-312025-03-3111131421211310108866442200
Download SVG
Download PNG
Download CSV
Somewhat Relevant
Moderately Relevant
Very Relevant
Highly Relevant
2025-03-252025-03-252025-03-262025-03-262025-03-272025-03-272025-03-282025-03-282025-03-292025-03-292025-03-312025-03-3143322312110108866442200
Download SVG
Download PNG
Download CSV

danske bank completes week 13 of share buyback program with significant transactions

Danske Bank A/S has initiated a share buy-back programme totaling DKK 5 billion, aiming to repurchase up to 45 million shares from 10 February 2025 to 30 January 2026. In week 13, the bank acquired 974,233 shares, bringing the total to 1,306,333 shares, representing 0.152% of its share capital.

nordic api gateway secures 5 million funding from danske bank and dnb

Nordic API Gateway has secured $5 million in funding from Danske Bank and DNB. This investment aims to enhance the company's capabilities in providing innovative financial solutions and services. The partnership underscores the growing interest in fintech advancements in the Nordic region.

Danske Bank takes a strong stance in Tech Stars competition

Danske Bank is taking its Tech Stars competition seriously, emphasizing its commitment to innovation in the fintech sector. The bank, along with its partners, utilizes cookies to enhance user experience, personalize features, and measure service effectiveness while navigating their website. Users consent to this by continuing to browse.

Elon Musk criticizes Minnesota governor for celebrating Tesla stock decline

Elon Musk criticized Minnesota Governor Tim Walz for celebrating Tesla's plummeting stock price, calling him a "huge jerk" during a Fox News appearance. Walz had previously joked about the stock drop at a Wisconsin event, which has sparked backlash against Tesla, including vandalism and protests from disgruntled owners and activists. Attacks on Tesla properties have surged, with incidents reported in cities like Portland and Seattle, prompting calls for severe penalties against the perpetrators.

ubs predicts over 50 percent recovery for novo nordisk shares

Novo Nordisk's shares have dropped over 20% this year, primarily due to disappointing results for its weight loss drug CagriSema and concerns about Wegovy's market performance against Eli Lilly's Zepbound. Despite this, UBS maintains a "buy" rating with a target price of 750 DKK, suggesting a potential 56% upside. Wall Street remains divided, with half of analysts recommending a buy and the other half advising to hold, but no sell ratings are present.

tesla shareholders consider protests and board changes amid musk's controversies

Tesla shareholders frustrated with Elon Musk have limited options for change, primarily through voting for new board members or selling their stock. Legal action against Musk is unlikely to succeed, as proving negligence or disloyalty is challenging. Shareholder discontent could escalate, especially among retail investors, potentially leading to significant actions reminiscent of past meme stock movements.

ubs maintains buy rating for novo nordisk with target price of 750 crowns

UBS has maintained its "Buy" rating for Novo Nordisk, setting a target price of 750 Danish crowns, influenced by current trends in weight loss drugs, particularly GLP-1. Analyst Jo Walton noted growth for Eli Lilly's Zepbound, while other competitors are seeing declines.

ubs rates novo nordisk as a buy with investment risks highlighted

UBS has rated Novo Nordisk as a 'Buy', but the information provided is for informational purposes only and does not constitute a recommendation to buy or sell. Investing in securities carries risks, including the potential total loss of capital. No liability for the accuracy or completeness of the information is assumed.

Novo Nordisk's strong sales driven by diabetes and obesity treatments

Novo Nordisk A/S focuses on the design, manufacture, and marketing of pharmaceutical products, with 93.6% of sales from diabetes and obesity treatments and 6.4% from rare diseases. Geographically, 57.6% of sales are in the United States, followed by Europe-Middle East-Africa at 20.8% and China at 6.4%.

Danske Bank faces delayed recovery as EPS forecasts are adjusted

Danske Bank A/S, Denmark's leading bank, operates in four main areas: retail banking, market and investment banking, insurance through Danica Pension, and asset management. By the end of 2024, the bank is expected to manage DKK 1,173.8 billion in current deposits and DKK 1,074.8 billion in current loans, reflecting a delayed recovery in its EPS forecasts.
Trending
Subcategory
Countries:
Companies:
Currencies:
People:

Machinary offers a groundbreaking, modular, and customizable solution that provides advanced financial news and statistical analysis. Our platform goes beyond traditional quantitative analysis, offering users a comprehensive understanding of real-time market dynamics, event detection, and risk analysis.

Address

Newsletter

© 2025 by Machinary.com - Version: 1.0.0.0. All rights reserved

Layout

Color mode

Theme mode

Layout settings

Seems like the connection with the server has been lost. It can be due to poor or broken network. Please hang on while we're trying to reconnect...
Oh snap! Failed to reconnect with the server. This is typically caused by a longer network outage, or if the server has been taken down. You can try to reconnect, but if that does not work, you need to reload the page.
Oh man! The server rejected the attempt to reconnect. The only option now is to reload the page, but be prepared that it won't work, since this is typically caused by a failure on the server.